tirzepatide fda news Says Compounded Must Exit the Market FDA says tirzepatide shortage is

They may slow down dose escalation or hold you at a lower maintenance dose for longer

Six-month data from pivotal trials documented average weight loss of 20 to 22 pounds, though individual results ranged from 10 to 35 pounds depending on starting body mass and adherence

Sergey Terushkin, MD, FACS Medically reviewed by Karla K

It's an injectable medication that helps control blood sugar levels and has also shown promise in aiding weight loss

Up to 82% relative reduction in liver fat at 24 weeks

If you are experiencing significant side effects, the solution is often not to stop the medication but to slow the titration